Developing Text-based Support for Parents of Adolescents After an Emergency Department Visit

April 18, 2024 updated by: Ewa Czyz, University of Michigan

Developing Text-based Support for Parents of Suicidal Adolescents After Emergency Department Visits: A Multi-component Intervention Pilot

The researchers seek to develop a text message intervention for caregivers of adolescents at elevated suicide risk following discharge from emergency department (ED) care.

Study Overview

Status

Completed

Conditions

Detailed Description

Participants in the trial included 120 youth-parent dyads (120 youths and 120 parents). As the ultimate focus of the intervention is on improving youth outcomes, participant-related descriptives are provided for youth participants, except where noted specifically to be parent-related data.

Study Type

Interventional

Enrollment (Actual)

240

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • The University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Parent eligibility:

Inclusion Criteria:

  • Parent of eligible teen

Exclusion Criteria:

  • Not owning a cell phone with text messaging capability.

Teen eligibility:

Inclusion Criteria:

  • Recent suicidal ideation (within last 2 weeks) and/or suicide attempt within the last month.

Exclusion Criteria:

  • Youth with severe cognitive impairment or altered mental status (e.g., psychosis, manic state)
  • Youth with severe aggression/agitation
  • No availability of a legal guardian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control (standard care)
Experimental: A-F texting component
The A-F texting component will include content consistent with best-practice recommendations for parents to buffer youth against suicide risk.
Over the course of the 6-week intervention parents in the A-F condition will receive 1 message each day.
Experimental: A-F texting plus P-F texting component
A-F texting plus P-F texting component arm includes the A-F component, as above, and P-F component. The P-F component includes an embedded micro-randomized trial (MRT) involving two daily randomizations to P-F message vs. no message conditions for the duration of the 6-week intervention. Participants who are randomized to this arm will be randomized twice each day (morning and evening) to either receive or not receive the P-F message at each randomization.
Over the course of the 6-week intervention parents in the A-F condition will receive 1 message each day.
Over the course of the 6 week intervention, parents will receive between 1-2 messages, depending on randomization (in addition to A-F component messages)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Eligible Youth-Parent Dyads Who Agree to Participate in the Study,
Time Frame: At the time of youth Emergency Department visit
Data represent participant dyads who were eligible and approached about study participation, and who agreed to take part in the study.
At the time of youth Emergency Department visit
Participant Dyads Who Completed Follow-up Assessments
Time Frame: Up to 12 weeks
Data was used to determine retention rate among the participant dyads. We report on follow up completion for both adolescent and caregiver members of the dyad.
Up to 12 weeks
Percentage of Participants Randomized to the Intervention Who Remained Active (Texting Arms Only)
Time Frame: Up to 6 weeks
Results represent parent participants who did not request stopping the intervention (i.e., did not request to stop receiving messages).
Up to 6 weeks
Participating Parents' Satisfaction With the Intervention (Texting Arms Only)
Time Frame: Up to 6 weeks
Measured using the Modified Client Satisfaction Questionnaire (CSQ), which was a 2-question survey. Each question had a range of 1-4. Adult participants were asked to rate both their overall satisfaction (1 meaning not satisfied to 4 meaning highly satisfied), and the likelihood that they would recommend their particular assigned intervention to a friend (1 meaning highly unlikely to 4 meaning highly likely).
Up to 6 weeks
Number of and Reasons for Active Withdrawals
Time Frame: Up to 12 weeks
Parent participant request to withdraw from the study. Study intention was to collect the number of and reasons for withdrawals, but the sole withdrawal did not provide a reason.
Up to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ewa Czyz, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 8, 2021

Primary Completion (Actual)

September 26, 2022

Study Completion (Actual)

September 26, 2022

Study Registration Dates

First Submitted

September 16, 2021

First Submitted That Met QC Criteria

September 16, 2021

First Posted (Actual)

September 28, 2021

Study Record Updates

Last Update Posted (Actual)

May 16, 2024

Last Update Submitted That Met QC Criteria

April 18, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00184110
  • 1R34MH124767-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide

Clinical Trials on A-F texting component

3
Subscribe